These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 15514398

  • 1. The effects of methylphenidate on neural systems of attention in attention deficit hyperactivity disorder.
    Shafritz KM, Marchione KE, Gore JC, Shaywitz SE, Shaywitz BA.
    Am J Psychiatry; 2004 Nov; 161(11):1990-7. PubMed ID: 15514398
    [Abstract] [Full Text] [Related]

  • 2. Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.
    Rubia K, Halari R, Cubillo A, Mohammad AM, Brammer M, Taylor E.
    Neuropharmacology; 2009 Dec; 57(7-8):640-52. PubMed ID: 19715709
    [Abstract] [Full Text] [Related]

  • 3. Drug-specific laterality effects on frontal lobe activation of atomoxetine and methylphenidate in attention deficit hyperactivity disorder boys during working memory.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.
    Psychol Med; 2014 Feb; 44(3):633-46. PubMed ID: 23597077
    [Abstract] [Full Text] [Related]

  • 4. Methylphenidate and atomoxetine normalise fronto-parietal underactivation during sustained attention in ADHD adolescents.
    Kowalczyk OS, Cubillo AI, Smith A, Barrett N, Giampietro V, Brammer M, Simmons A, Rubia K.
    Eur Neuropsychopharmacol; 2019 Oct; 29(10):1102-1116. PubMed ID: 31358436
    [Abstract] [Full Text] [Related]

  • 5. Methylphenidate normalizes frontocingulate underactivation during error processing in attention-deficit/hyperactivity disorder.
    Rubia K, Halari R, Mohammad AM, Taylor E, Brammer M.
    Biol Psychiatry; 2011 Aug 01; 70(3):255-62. PubMed ID: 21664605
    [Abstract] [Full Text] [Related]

  • 6. Striatal creatine and glutamate/glutamine in attention-deficit/hyperactivity disorder.
    Carrey NJ, MacMaster FP, Gaudet L, Schmidt MH.
    J Child Adolesc Psychopharmacol; 2007 Feb 01; 17(1):11-7. PubMed ID: 17343550
    [Abstract] [Full Text] [Related]

  • 7. Neurofunctional effects of methylphenidate and atomoxetine in boys with attention-deficit/hyperactivity disorder during time discrimination.
    Smith A, Cubillo A, Barrett N, Giampietro V, Simmons A, Brammer M, Rubia K.
    Biol Psychiatry; 2013 Oct 15; 74(8):615-22. PubMed ID: 23731741
    [Abstract] [Full Text] [Related]

  • 8. Functional dysconnectivity of corticostriatal circuitry and differential response to methylphenidate in youth with attention-deficit/hyperactivity disorder.
    Hong SB, Harrison BJ, Fornito A, Sohn CH, Song IC, Kim JW.
    J Psychiatry Neurosci; 2015 Jan 15; 40(1):46-57. PubMed ID: 25266402
    [Abstract] [Full Text] [Related]

  • 9. Gait in attention deficit hyperactivity disorder : effects of methylphenidate and dual tasking.
    Leitner Y, Barak R, Giladi N, Peretz C, Eshel R, Gruendlinger L, Hausdorff JM.
    J Neurol; 2007 Oct 15; 254(10):1330-8. PubMed ID: 17401735
    [Abstract] [Full Text] [Related]

  • 10. Shared and drug-specific effects of atomoxetine and methylphenidate on inhibitory brain dysfunction in medication-naive ADHD boys.
    Cubillo A, Smith AB, Barrett N, Giampietro V, Brammer MJ, Simmons A, Rubia K.
    Cereb Cortex; 2014 Jan 15; 24(1):174-85. PubMed ID: 23048018
    [Abstract] [Full Text] [Related]

  • 11. A positron emission tomography study of nigro-striatal dopaminergic mechanisms underlying attention: implications for ADHD and its treatment.
    del Campo N, Fryer TD, Hong YT, Smith R, Brichard L, Acosta-Cabronero J, Chamberlain SR, Tait R, Izquierdo D, Regenthal R, Dowson J, Suckling J, Baron JC, Aigbirhio FI, Robbins TW, Sahakian BJ, Müller U.
    Brain; 2013 Nov 15; 136(Pt 11):3252-70. PubMed ID: 24163364
    [Abstract] [Full Text] [Related]

  • 12. Methylphenidate enhances cognitive performance in adults with poor baseline capacities regardless of attention-deficit/hyperactivity disorder diagnosis.
    Agay N, Yechiam E, Carmel Z, Levkovitz Y.
    J Clin Psychopharmacol; 2014 Apr 15; 34(2):261-5. PubMed ID: 24525641
    [Abstract] [Full Text] [Related]

  • 13. Prefrontal grey and white matter neurometabolite changes after atomoxetine and methylphenidate in children with attention deficit/hyperactivity disorder: a (1)H magnetic resonance spectroscopy study.
    Husarova V, Bittsansky M, Ondrejka I, Dobrota D.
    Psychiatry Res; 2014 Apr 30; 222(1-2):75-83. PubMed ID: 24679996
    [Abstract] [Full Text] [Related]

  • 14. Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder.
    Schulz KP, Fan J, Bédard AC, Clerkin SM, Ivanov I, Tang CY, Halperin JM, Newcorn JH.
    Arch Gen Psychiatry; 2012 Sep 30; 69(9):952-61. PubMed ID: 22945622
    [Abstract] [Full Text] [Related]

  • 15. Influence of methylphenidate on spatial attention asymmetry in adolescents with attention deficit hyperactivity disorder (ADHD): preliminary findings.
    Silk TJ, Newman DP, Eramudugolla R, Vance A, Bellgrove MA.
    Neuropsychologia; 2014 Apr 30; 56():178-83. PubMed ID: 24486422
    [Abstract] [Full Text] [Related]

  • 16. Verbal working memory-related functional connectivity alterations in boys with attention-deficit/hyperactivity disorder and the effects of methylphenidate.
    Wu ZM, Bralten J, An L, Cao QJ, Cao XH, Sun L, Liu L, Yang L, Mennes M, Zang YF, Franke B, Hoogman M, Wang YF.
    J Psychopharmacol; 2017 Aug 30; 31(8):1061-1069. PubMed ID: 28656805
    [Abstract] [Full Text] [Related]

  • 17. Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.
    Zang YF, Jin Z, Weng XC, Zhang L, Zeng YW, Yang L, Wang YF, Seidman LJ, Faraone SV.
    Brain Dev; 2005 Dec 30; 27(8):544-50. PubMed ID: 15876503
    [Abstract] [Full Text] [Related]

  • 18. Autonomic correlates at rest and during evoked attention in children with attention-deficit/hyperactivity disorder and effects of methylphenidate.
    Negrao BL, Bipath P, van der Westhuizen D, Viljoen M.
    Neuropsychobiology; 2011 Dec 30; 63(2):82-91. PubMed ID: 21178382
    [Abstract] [Full Text] [Related]

  • 19. Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task.
    Bush G, Spencer TJ, Holmes J, Shin LM, Valera EM, Seidman LJ, Makris N, Surman C, Aleardi M, Mick E, Biederman J.
    Arch Gen Psychiatry; 2008 Jan 30; 65(1):102-14. PubMed ID: 18180434
    [Abstract] [Full Text] [Related]

  • 20. The interactive effects of test-retest and methylphenidate administration on cognitive performance in youth with ADHD: A double-blind placebo-controlled crossover study.
    Horowitz I, Avirame K, Naim-Feil J, Rubinson M, Moses E, Gothelf D, Levit-Binnun N.
    Psychiatry Res; 2020 Sep 30; 291():113056. PubMed ID: 32554183
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.